Estazolam

This classification denotes a benzodiazepine with the molecular formula C16H11ClN4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36S3EQV54C, chemically known as 8-chloro-6-phenyl-4h-s-triazolo(4,3-a)(1,4)benzodiazepine (iupac) but generally known as estazolam, which bears US NIH Compound Identifier 3261. European Medicines Agency schedules Estazolam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07241MIG. The term ESTAZOLAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules estazolam in its Anatomical Therapeutic Chemical (ATC) Classification. ESTAZOLAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule estazolam under HS 29339190 and SITC 51577. As of Q4 2014, ESTAZOLAM remains the US FDA Preferred Term for this commodity. Estazolam bears US NLM identifiers UMLS ID C0014892 and NCI Concept Code C47520. SMILES: CLC1CC2C(N3C(NNC3)CN=C2C2CCCCC2)CC1.